CORDIS
EU research results

CORDIS

English EN

Sensory and Biomechanical Markers in Diabetic Neuropathy of the Gut. Basic Investigations and New Approaches for Treatment

Objective

DIAMARK is focused on analysing the pathophysiology of diabetic neuropathy and to determine better biomarkers of the complications and approaches for intervention. Due to lack of standardisation, there are no accepted biomarkers to evaluate the neuropathy and its involvement in the GI tract. Diabetes mellitus (DM) is one of the most common endocrine disorders affecting almost 6% (app. 246 million people) worldwide (http://www.idf.org). DM is a chronic disease requiring lifelong attention in order to limit the development of potentially devastating complications and to manage them if they occur. Gastrointestinal (GI) disorders are common and closely associated with autonomic neuropathy. Several studies addressed the visceral sensory function in DM and demonstrated abnormalities in perception thresholds, vagal tone and evoked brain potentials in patients with autonomic neuropathy. Thus, DM-related changes may be located in the enteric, the peripheral and in the CNS. Several clinical, neurophysiological and biochemical test for neuropathy have been proposed but they are not reliable and valid. This makes is crucial to develop better biomarkers for GI neuropathy and associated complications, to test the reliability and validity under controlled circumstances using advanced multimodal methods and to follow the biomarkers during new treatments. This proposal aims at determining new biomarkers related to the enteric nervous system (response to stimulation), peripheral nerves (recordings from visceral nerves) and central nervous system (evoked brain potentials and computation of the brain sources activated). After reliability testing under controlled circumstances in the laboratory and the clinic, the validity of the biomarkers will be followed during the most promising new treatments with gastric pacing and bypass surgery. The highly skilled academic and industrial partners of the consortium are selected based on their work on various aspects of the proposed framework.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

AALBORG SYGEHUS

Address

Hobrovej 42a
9000 Aalborg

Denmark

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

EU Contribution

€ 736 000

Administrative Contact

Hans Gregersen (Prof.)

Participants (5)

Sort alphabetically

Sort by EU Contribution

Expand all

GOETEBORGS UNIVERSITET

Sweden

EU Contribution

€ 288 000

Belbetegek Jobb Ellatasaert Alapitvany

Hungary

EU Contribution

€ 70 400

AARHUS UNIVERSITETSHOSPITAL

Denmark

EU Contribution

€ 258 000

Diagles Limited

Ireland

EU Contribution

€ 121 200

DITENS A/S

Denmark

EU Contribution

€ 302 400

Project information

Grant agreement ID: 223630

Status

Closed project

  • Start date

    1 November 2008

  • End date

    31 October 2011

Funded under:

FP7-HEALTH

  • Overall budget:

    € 2 270 334

  • EU contribution

    € 1 776 000

Coordinated by:

AALBORG SYGEHUS

Denmark